Identification of a Homozygous Missense Mutation in the TYR Gene in a Chinese Family with OCA1

Abstract

Oculocutaneous albinism (OCA) is an autosomal recessive pigmentation abnormality, characterized by variable hair, skin, and ocular hypopigmentation. OCA1 is the most frequent subtype of OCA, caused by mutations in the tyrosinase gene (TYR). In this study, we investigated the genetic mutation of a Chinese family with a female OCA patient who came for genetic counseling before pregnancy. Complete physical examination was performed, and DNA from blood samples was collected from the family members. Mutations of TYR, OCA2, and SLC45A2 genes were examined in the proband, and verified in her parents by Sanger sequencing. Large deletion or duplication of TYR and OCA2 genes was detected by multiplex ligation-dependent probe amplification (MLPA). A homozygous TYR c.307T>C (p.Cys103Arg) missense mutation was identified in the proband, and both parents were heterozygous carriers. No large deletion or duplication was found in the proband. This mutation was absent in 1000G, ExAC, or HGMD database, and multiple lines of in silico tools supported a deleterious effect. These results suggest that TYR c.307T>C mutation might be responsible for OCA1, and our study further expands the mutation spectrum of OCA1 in the Chinese population.

Keywords

oculocutaneous albinism / TYR / mutation / multiplex ligation-dependent probe amplification

References

[1] QiuB, MaT, PengC, et al.. Identification of Five Novel Variants in Chinese Oculocutaneous Albinism by Targeted Next-Generation Sequencing. Genet Test Mol Biomarkers, 2018, 22(4): 252-258

[2] FábosB, FarkasK, TóthL, et al.. Delineating the genetic heterogeneity of OCA in Hungarian patients. Eur J Med Res, 2017, 22(1): 20-27

[3] GulH, AliMZ, KhanE, et al.. Ophthalmo-genetic analysis of Pakistani patients with nonsyndromic oculocutaneous albinism through whole exome sequencing. JPMA, 2017, 67(5): 790-792

[4] WangX, ZhuY, ShenN, et al.. Mutational analysis of a Chinese family with oculocutaneous albinism type 2. Oncotarget, 2017, 8(41): 70 345-70 355

[5] SimeonovDR, WangX, WangC, et al.. DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics. Hum Mutat, 2013, 34(6): 827-835

[6] GargiuloA, TestaF, RossiS, et al.. Molecular and clinical characterization of albinism in a large cohort of Italian patients. Invest Ophthalmol Vis Sci, 2011, 52(3): 1281-1289

[7] MangaP, KerrR, RamsayM, et al.. Biology and genetics of oculocutaneous albinism and vitiligo-common pigmentation disorders in southern Africa. S Afr Med J, 2013, 103(12): 984-988

[8] SuzukiT, TomitaY. Recent advances in genetic analyses of oculocutaneous albinism types 2 and 4. J Dermatol Sci, 2008, 51(1): 1-9

[9] KausarT, BhattiMA, AliM, et al.. OCA5, a novel locus for non-syndromic oculocutaneous albinism, maps to chromosome 4q24. Clin Genet, 2013, 84(1): 91-93

[10] VenianiE, MauriL, ManfrediniE, et al.. Detection of the first OCA6 Italian patient in a large cohort of albino subjects. J Dermatol Sci, 2016, 81(3): 208-209

[11] WangX, ZhuY, ShenN, et al.. Mutation analysis of a Chinese family with oculocutaneous albinism. Oncotarget, 2016, 7(51): 84 981-84 988

[12] LiJ, ShiL, ZhangK, et al.. VarCards: an integrated genetic and clinical database for coding variants in the human genome. Nucleic Acids Res, 2018, 46: D1039-D1048

[13] KumarP, HenikoffS, NgPC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc, 2009, 4(7): 1073-1081

[14] SchwarzJM, CooperDN, SchuelkeM, et al.. MutationTaster2: mutation prediction for the deepsequencing age. Nat Methods, 2014, 11(4): 361-362

[15] AdzhubeiIA, SchmidtS, PeshkinL, et al.. A method and server for predicting damaging missense mutations. Nat Methods, 2010, 7(4): 248-249

[16] GoldbergRA, LallyDR, HeierJS. Oculocutaneous albinism. JAMA Ophthalmol, 2015, 133(3): e143518

[17] BuitragoE, VuillamyA, BoumendjelA, et al.. Exploring the interaction of N/S compounds with a dicopper center: tyrosinase inhibition and model studies. Inorg Chem, 2014, 53(24): 12 848-12 858

[18] RezaeiM, MohammadiHT, MahdaviA, et al.. Evaluation of thiazolidinone derivatives as a new class of mushroom tyrosinase inhibitors. Int J Biol Macromol, 2018, 108(1): 205-213

[19] Ghodsinejad KalahroudiV, KamalidehghanB A, KaniA, et al.. Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1). PloS one, 2014, 9(9): e106656-e106665

[20] WeiA, WangY, LongY, et al.. A comprehensive analysis reveals mutational spectra and common alleles in Chinese patients with oculocutaneous albinism. J Invest Dermatol, 2010, 130(3): 716-724